Trade Summary

1 week ago, Cohen Cheryl, serving as Dir at ImmunityBio, Inc. (IBRX), sold 131,210 shares at $9.50 per share, for a total transaction value of $1,246,941.11. Following this transaction, Cohen Cheryl now holds 125,386 shares of IBRX.

This sale represents a 51.13% decrease in Cohen Cheryl's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 (accepted Jul 6, 8:26 PM ET), 5 days after the trade was made.

ImmunityBio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.